Arizona Oncology Associates, PC-HAL
Phoenix, Arizona 85027
0 studies enrolling now · 19 studies all time
What they study most
Breast Cancer, Carcinoma, Renal Cell, Cervical Cancer, Chemotherapy-induced Nausea and Vomiting, Chronic Lymphocytic Leukemia (CLL), Chronic Myeloid Leukemia, Complete Response, Endometrial Neoplasms, Epithelial Ovarian Cancer, FIGO Stage III-IV, Fallopian Tube Cancer, HER2 Positive Breast Cancer
Studies at this site
- A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma — Completed
- Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775]) — Completed
- A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HEC — Completed
- Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer — Completed
- A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy — Running, not enrolling
- FOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian Cancer — Stopped early
- Multiple Myeloma Patient Registry — Stopped early
- Tomivosertib Combined With Pembrolizumab in Subjects With PD-L1 Positive NSCLC (KICKSTART) — Status unconfirmed
- A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer — Completed
- A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer — Completed
- A Study to Compare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory Advanced Renal Cell Carcinoma (RCC) — Completed
- A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200) — Completed
- Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100) — Stopped early
- informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia — Completed
- Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting — Completed
- Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer — Completed
- NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer — Stopped early
- Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100) — Stopped early
- Study of Brentuximab Vedotin Combined With RCHOP or RCHP in Front-line Treatment of Patients With Diffuse Large B-cell Lymphoma (DLBCL) — Stopped early